Literature DB >> 3806590

2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.

E von Angerer, J Strohmeier.   

Abstract

Hydroxy-2-phenylindoles carrying substituted benzyl groups and similar substituents at the nitrogen were synthesized and tested for their ability to displace estradiol from its receptor. All of the derivatives tested exhibited high binding affinities for the calf uterine estrogen receptor, with RBA values ranging from 0.55 to 16 (estradiol 100). The mouse uterine weight tested revealed only low estrogenicity for this class of compounds. Several derivatives showed antiestrogenic activity with a maximum inhibition of estrone-stimulated uterine growth of 40%. Two of the compounds (6c, 21c) were tested for antitumor activity in dimethylbenanthracene- (DMBA-) induced estrogen-dependent rat mammary tumors. Only the 4-cyanobenzyl derivative 21c was active. After 4 weeks of treatment with 12 mg/kg (6 times/week), the average tumor area was decreased by 57% (control +204%). In vitro, an inhibitory effect of 21b was only observed with hormone-sensitive MCF-7 breast cancer cells but not with hormone-independent MDA-MB 231 cells. These results make a mode of action involving the estrogen receptor system likely.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3806590     DOI: 10.1021/jm00384a022

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Androgen-linked alkylating agents: biological activity in methylnitrosourea-induced rat mammary carcinoma.

Authors:  H P Brix; M R Berger; M R Schneider; W C Tang; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Tethered indoles as functionalizable ligands for the estrogen receptor.

Authors:  Bridget G Trogden; Sung Hoon Kim; Shuyi Lee; John A Katzenellenbogen
Journal:  Bioorg Med Chem Lett       Date:  2008-11-18       Impact factor: 2.823

3.  Synthesis and molecular docking of novel non-competitive antagonists of GluK2 receptor.

Authors:  Agnieszka A Kaczor; Tomasz Wróbel; Christiane Kronbach; Klaus Unverferth; Tomasz Stachal; Dariusz Matosiuk
Journal:  Med Chem Res       Date:  2014-07-24       Impact factor: 1.965

4.  A Quick Access to Structurally Diverse Triazoloquinazoline Heterocycles via the MIL-101(Cr)-Catalyzed One-Pot Multi-Component Reaction of a Series of Benzaldehydes, Dimedone, and 1H-1,2,4-Triazol-3-Amine Under Green Conditions.

Authors:  Pezhman Shiri; Esmaeil Niknam; Jasem Aboonajmi; Ali Khalafi-Nezhad; Ali Mohammad Amani
Journal:  Front Chem       Date:  2022-07-25       Impact factor: 5.545

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.